K

Koninklijke Philips NV
MIL:PHIA

Watchlist Manager
Koninklijke Philips NV
MIL:PHIA
Watchlist
Price: 18.62 EUR -0.82% Market Closed
Market Cap: €16.4B

EV/IC

0.9
Current
No historical data
Comparison unavailable

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
0.9
=
Enterprise Value
€22.6B
/
Invested Capital
€25.6B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
0.9
=
Enterprise Value
€22.6B
/
Invested Capital
€25.6B

Valuation Scenarios

Koninklijke Philips NV is trading above its 3-year average

If EV/IC returns to its 3-Year Average (0.9), the stock would be worth €18.62 (0% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
0%
Maximum Upside
+31%
Average Upside
8%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 0.9 €18.62
0%
3-Year Average 0.9 €18.62
0%
5-Year Average 0.9 €18.62
0%
Industry Average 0.9 €18.62
0%
Country Average 1.2 €24.32
+31%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close
Market Cap EV/IC P/E
NL
Koninklijke Philips NV
MIL:PHIA
17.5B EUR 0.9 -21.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.5B USD 11 56.9
US
Abbott Laboratories
NYSE:ABT
157.7B USD 2.1 24.8
US
Stryker Corp
NYSE:SYK
120.5B USD 2.9 34.7
IE
Medtronic PLC
NYSE:MDT
103.9B USD 1.5 22.3
US
Boston Scientific Corp
NYSE:BSX
85.4B USD 2.3 23.7
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD 4.9 44.6
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 1.2 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
44.7B USD 14.9 42.8
US
Becton Dickinson and Co
NYSE:BDX
42.4B USD 1.2 24.2
US
Resmed Inc
NYSE:RMD
31.1B USD 4.2 20.1

Market Distribution

In line with most companies in Netherlands
Percentile
35th
Based on 560 companies
35th percentile
0.9
Low
0 — 0.8
Typical Range
0.8 — 1.9
High
1.9 —
Distribution Statistics
Netherlands
Min 0
30th Percentile 0.8
Median 1.2
70th Percentile 1.9
Max 36 345.7

Koninklijke Philips NV
Glance View

Koninklijke Philips NV, more commonly known as Philips, has transformed itself from its origins as a humble light bulb manufacturer in 1891 into a global leader in health technology. The company, headquartered in Amsterdam, embodies innovation and resilience, consistently reinventing itself to meet the needs of an ever-evolving world. Throughout the 20th century, Philips expanded its portfolio, venturing into consumer electronics, from televisions to audio equipment, earning it household recognition around the globe. However, the brand's recent strategic pivot towards focusing primarily on health technology is a testament to its agile vision for long-term growth and sustainability. Today, Philips operates through several key segments: Diagnosis & Treatment, Connected Care, and Personal Health. The company generates the bulk of its revenues by offering sophisticated medical imaging systems, patient monitoring solutions, and consumer health products. Its diagnostic imaging tools, like MRI and CT scanners, play a crucial role in the early detection of diseases, while its patient monitoring solutions ensure continuous care both in hospitals and remotely. Meanwhile, the personal health division supplies consumers with products designed to promote well-being, such as electronic toothbrushes and personal grooming devices. Through a strong commitment to innovation and a focus on healthcare outcomes, Philips continues to carve out its niche as a pivotal player in health technology, effectively bridging the gaps between technology and wellness.

PHIA Intrinsic Value
Not Available
K
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett